FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and concerns diagnosis of a functional class of chronic cardiac failure (CCF). The diagnosis is implemented by developed formula taking into account assessed variations of a left ventricular end diastolic and a diastolic septal wall thickness determined by echocardiography, as well as variations of NT-terminal fragments of a brain natriuretic peptide precursor. The functional class of CCF is verified by a relation of expected values and the functional class NYHA of CCF.
EFFECT: method enables the adequate diagnosis of the functional class of CCF, including in the patients with counterindications for physical and pharmacological loading tests, as well as with no equipment required for stress tests.
4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DETERMINING VENOUS STASIS ON SYSTEMIC CIRCULATION IN PATIENTS WITH CHRONIC HEART FAILURE | 2010 |
|
RU2449289C2 |
| SCREENING DIAGNOSTIC TECHNIQUE FOR LEFT VENTRICULAR MYOCARDIAL HYPERTROPHY IN FEMALES SUFFERING HYPERTENSIVE DISEASE | 2010 |
|
RU2454672C2 |
| METHOD FOR DETERMINING DIASTOLIC DYSFUNCTION OF THE RIGHT VENTRICLE | 2018 |
|
RU2696076C1 |
| METHOD FOR PREDICTING PROGRESSION OF ANTHRACYCLINE-INDUCED CHRONIC HEART FAILURE IN PATIENTS WITH BREAST CANCER WITHIN 24 MONTHS | 2022 |
|
RU2793672C1 |
| METHOD FOR PERSONALIZED SELECTION OF PATIENTS WITH ANTHRACYCLINE-INDUCED CARDIOMYOPATHY AFTER POLYCHEMOTHERAPY OF BREAST CANCER FOR EFFECTIVE TREATMENT WITH CARVEDILOL | 2021 |
|
RU2778612C1 |
| A METHOD FOR DIAGNOSING HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH CORONARY ARTERY DISEASE ON THE BACKGROUND OF NON-OCCLUSIVE ATHEROSCLEROSIS OF THE CORONARY ARTERIES | 2022 |
|
RU2789429C1 |
| METHOD FOR PREDICTION OF ATRIAL FIBRILLATION DEVELOPMENT IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME | 2022 |
|
RU2793677C1 |
| METHOD FOR PREDICTING RISKS OF PROGRESSION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS WITH NON-OBSTRUCTIVE ATHEROSCLEROSIS OF CORONARY ARTERIES DURING 12 MONTHS OF OBSERVATION | 2023 |
|
RU2804705C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE DECOMPENSATION OF ISCHEMIC CHRONIC HEART FAILURE WITH SYSTOLIC DYSFUNCTION OF THE LEFT VENTRICLE OF THE HEART AFTER COMPLETE MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770271C1 |
| METHOD FOR PREDICTING THE RISK OF DEATH IN PATIENTS ONE YEAR AFTER ACUTE CORONARY SYNDROME AND PERCUTANEOUS CORONARY INTERVENTION | 2022 |
|
RU2791657C1 |
